Clinical Trial
Logistics

- 150°C Liquid Nitrogen

- 80°C and -30°C Freezers

+ 4°C Refrigerators

Ambient

Cryo Store’s Clinical Trial Logistics services take away all logistic worries from pharma companies, hospitals and medical institutes who participate in clinical trials. Clinical trials offer serious challenges in both cold chain management as actual logistics. Not to mention all administration and safety measures that are involved in the international exchange of bio products. Whether you need to send urine, blood or biopsy samples; under ambient, refrigerated or frozen conditions, we supply the right materials to ensure proper packaging and cooling agents to keep your samples in perfect condition during transport. We also provide the dry ice. Our dry ice provisioning service combines our expertise with world class courier services for a fraction of the costs of alternative premium suppliers. 


Cryo Store’s Clinical trial logistics services: our solution for your problem. 

Bio Storage

Cryo Store’s facilities provides a choice of temperature ranges for sample storage:

- 150°C Liquid Nitrogen

- 80°C and -30°C Freezers

+ 4°C Refrigerators

Ambient

Safe

Our storage facilities ensure sound and safe storage of your samples. Apart from the obvious safety measures against burglary and fire, the temperatures of all storage locations, LN2 vessels, freezers and refrigerators, are continuously monitored through our validated network and equiped with a temperature alarm system. In addition, we have automatic LN2 filling, CO2-backup on the -80°C, an emergency power supply and plenty of dry ice in stock. Safety is guaranteed 24/7.


Cryo Store’s Bio Storage services: cold and safe

Cold Chain 
Solutions

Cryo Store can boast years of experience with Cold Chain Solutions; the entire process of Cooled Storage, Packaging and the Worldwide Logistics of temperature controlled goods. Our central location in the Netherlands, in the center of international logistics, enables us to be quick and safe in delivering your packages, to destinations anywhere in the world.


We comply to current safety regulations and quality standards, we monitor shipments from door to door and intervene when required. We apply our knowledge and experience in several markets wherein temperature control is a key factor, such as biotech/life sciences and food industries.

Biotech/Life Sciences Warehousing

Many products for scientific research are produced outside Europe. Importing them, and delivering on time, on temperature and against reasonable costs is often a challenge. Every delay at customs may endanger the quality of the packaged goods. And there are challenges with VAT-payments as well. All these issues can be circumvented by engaging Cryo Store as your European logistics warehouse. 


Cryo Store takes these worries out of your hands and mind.

  • We support VAT registration, reclaim and reporting.
  • We support the importion of goods.
  • We facilitate temperature controlled warehousing and stock management.
  • We package (eg kit assembly) and re-package.
  • We process orders, package and transport your goods.
  • We pick up and dispatch goods, we track and trace and report to you.
Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue